Evolution of Translational Omics : Lessons Learned and the Path Forward

個数:

Evolution of Translational Omics : Lessons Learned and the Path Forward

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 354 p.
  • 言語 ENG
  • 商品コード 9780309224185
  • DDC分類 572.33

Full Description

Technologies collectively called omics enable simultaneous measurement of an enormous number of biomolecules; for example, genomics investigates thousands of DNA sequences, and proteomics examines large numbers of proteins. Scientists are using these technologies to develop innovative tests to detect disease and to predict a patient's likelihood of responding to specific drugs. Following a recent case involving premature use of omics-based tests in cancer clinical trials at Duke University, the NCI requested that the IOM establish a committee to recommend ways to strengthen omics-based test development and evaluation. This report identifies best practices to enhance development, evaluation, and translation of omics-based tests while simultaneously reinforcing steps to ensure that these tests are appropriately assessed for scientific validity before they are used to guide patient treatment in clinical trials.

Table of Contents

Front Matter
Summary
1 Introduction
2 Omics-Based Clinical Discovery: Science, Technology, and Applications
3 Best Practices for Omics-Based Test Validation Prior to Use for Patient Management Decisions in a Clinical Trial Setting
4 Evaluation of Omics-Based Tests for Clinical Utility and Use
5 Responsible Parties
6 Lessons from the Case Studies
Appendix A: Case Studies
Appendix B: Gene ExpressionBased Tests Developed at Duke University and Used in Clinical Trials
Appendix C: Introduction to Biomarkers
Appendix D: Reporting Guidelines
Appendix E: Committee Member and Staff Biographies
Appendix F: Information Gathering Sessionsand Speakers
Acronyms and Abbreviations
Glossary

Contents

1 Front Matter; 2 Summary; 3 1 Introduction; 4 2 Omics-Based Clinical Discovery: Science, Technology, and Applications; 5 3 Best Practices for Omics-Based Test Validation Prior to Use for Patient Management Decisions in a Clinical Trial Setting; 6 4 Evaluation of Omics-Based Tests for Clinical Utility and Use; 7 5 Responsible Parties; 8 6 Lessons from the Case Studies; 9 Appendix A: Case Studies; 10 Appendix B: Gene ExpressionBased Tests Developed at Duke University and Used in Clinical Trials; 11 Appendix C: Introduction to Biomarkers; 12 Appendix D: Reporting Guidelines; 13 Appendix E: Committee Member and Staff Biographies; 14 Appendix F: Information Gathering Sessionsand Speakers; 15 Acronyms and Abbreviations; 16 Glossary

最近チェックした商品